1. WHO, Obesity and overweight fact sheet, (2016). http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed June 11, 2020).
2. EMA, Guideline on clinical evaluation of medicinal products used in weight management, (2016). www.ema.europa.eu/contact (accessed July 8, 2020).
3. FDA, Safety clinical trial shows possible increased risk of cancer with weight- loss medicine Belviq, Belviq XR (lorcaserin), (2020). https://www.fda.gov/drugs/drug-safety-and-availability/safety-clinical-trial-shows-possible-increased-risk-cancer-weight-loss-medicine-belviq-belviq-xr (accessed July 8, 2020).
4. Pharmacological treatment of obesity;Mancini;Arq. Bras. Endocrinol. Metab.,2006
5. Adulterated pharmaceutical chemicals in botanical dietary supplements: novel screening approaches;Liu;Rev. Anal. Chem.,2017